Manufacturers Life Insurance Company, The Zynerba Pharmaceuticals, Inc. Transaction History

Manufacturers Life Insurance Company, The

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 10, 2020	SELL	$3.31 - $6.54 $54,178 - $107,046	-16,368 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$2.9 - $6.16 $5,060 - $10,749	1,745 Added 11.93%	16,368 $63,000
Q4 2019 Feb 14, 2020	BUY	$5.61 - $8.57 $2,395 - $3,659	427 Added 3.01%	14,623 $88,000
Q3 2019 Nov 12, 2019	BUY	$7.56 - $15.44 $3,288 - $6,716	435 Added 3.16%	14,196 $110,000
Q2 2019 Aug 14, 2019	BUY	$5.4 - $15.5 $74,309 - $213,295	13,761 New	13,761 $186,000
Q3 2018 Nov 14, 2018	SELL	$5.59 - $10.45 $3,298 - $6,165	-590 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$7.98 - $12.39 $29,470 - $45,756	-3,693 Reduced 86.22%	590 $6,000
Q1 2018 May 15, 2018	SELL	$8.49 - $13.46 $25,724 - $40,783	-3,030 Reduced 41.43%	4,283 $37,000
Q4 2017 Feb 08, 2018	BUY	$8.69 - $14.59 $59,178 - $99,357	6,810 Added 1353.88%	7,313 $92,000
Q3 2017 Nov 14, 2017	BUY	$5.73 - $9.44 $2,882 - $4,748	503	503 $4,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.